文献速递乳腺乳腺X线

对有小叶瘤变史的中间风险女性进行对比增强数字乳腺X线筛查

Contrast-Enhanced Digital Mammography Screening for Intermediate-Risk Women With a History of Lobular Neoplasia.
PubMed 文献 · AJR Am J Roentgenol · 2021-03-31

本研究回顾性观察了132例有小叶瘤变活检史、无其他风险因素的中间风险女性,共306次对比增强数字乳腺X线(CEDM)筛查,以病理或12个月影像随访为参考标准,CEDM检出癌症6例,敏感度100%、特异度88%(95%CI 84-92%)、阴性预测值100%、准确率88%(95%CI 84-92%),阳性似然比8.33。作者认为CEDM在这类人群筛查中有前景,但需更大样本继续研究以确定真实敏感度和阳性预测值。

要点

  • 有小叶瘤变史且无其他风险因素的女性中,CEDM筛查敏感度100%、特异度88%(95%CI 84-92%)。
  • CEDM阳性似然比8.33,即乳腺癌患者CEDM阳性的可能性是无癌者的8.3倍。
  • 作者认为CEDM在这类中间风险人群筛查中有前景,但需更大样本继续研究。

核心结论

  • CEDM在有个人小叶瘤变史的患者中作为乳腺癌筛查手段显示出前景;需要更大患者群体继续研究以确定CEDM在这些患者中的真实敏感度和阳性预测值。

研究设计与样本

  • 经机构审查委员会批准的观察性回顾性研究,回顾放射科数据库,纳入2012年12月至2019年2月期间在本机构接受筛查CEDM、有乳腺活检示小叶瘤变个人史的患者,共132例女性、306次CEDM检查;CEDM由乳腺影像专科放射科医生结合临床病史和既往乳腺影像解读;以病理或12个月影像随访为参考标准。

诊断标准与关键数值

  • CEDM检出癌症6例,总体敏感度100%,特异度88%(95%CI 84-92%),阴性预测值100%,准确率88%(95%CI 84-92%),阳性似然比8.33。

局限性

  • 需要更大患者群体继续研究以确定CEDM在这些患者中的真实敏感度和阳性预测值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The objective of this study was to assess to the role of contrast-enhanced digital mammography (CEDM) as a screening tool in women at intermediate risk for developing breast cancer due to a personal history of lobular neoplasia without additional risk factors. MATERIALS AND METHODS. In this institutional review board-approved, observational, retrospective study, we reviewed our radiology department database to identify patients with a personal history of breast biopsy yielding lobular neoplasia who underwent screening CEDM at our institution between December 2012 and February 2019. A total of 132 women who underwent 306 CEDM examinations were included. All CEDM examinations were interpreted by dedicated breast imaging radiologists in conjunction with a review of the patient's clinical history and available prior breast imaging. In statistical analysis, sensitivity, specificity, NPV, positive likelihood ratio, and accuracy of CEDM in detecting cancer were determined, with pathology or 12-month imaging follow-up serving as the reference standard. RESULTS. CEDM detected cancer in six patients and showed an overall sensitivity of 100%, specificity of 88% (95% CI, 84-92%), NPV of 100%, and accuracy of 88% (95% CI, 84-92%). The positive likelihood ratio of 8.33 suggested that CEDM findings are 8.3 times more likely to be positive in an individual with breast cancer when compared with an individual without the disease. CONCLUSION. CEDM shows promise as a breast cancer screening examination in patients with a personal history of lobular neoplasia. Continued investigation with a larger patient population is needed to determine the true sensitivity and positive predictive value of CEDM for these patients.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Hogan MP, Amir T, Sevilimedu V, et al. Contrast-Enhanced Digital Mammography Screening for Intermediate-Risk Women With a History of Lobular Neoplasia. AJR Am J Roentgenol. 2021. PMID: 33787291. doi:10.2214/AJR.20.23480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。